DAB2IP and nonpapillary renal cell carcinoma: In this study, we identified one CpG methylation biomarker located at upstream of the transcription start site (UTSS) of DAB2IP (DAB2IP CpG1) that predicted survival in ccRCC patients from The Cancer Genome Atlas (TCGA) study.